Five novel mutations in the C1 inhibitor gene (C1NH) leading to a premature stop codon in patients with type I hereditary angioedema
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
11933207
DOI
10.1002/humu.9029
PII: 10.1002/humu.9029
Knihovny.cz E-zdroje
- MeSH
- angioedém klasifikace genetika MeSH
- exony genetika MeSH
- inhibiční protein komplementu C1 MeSH
- komplement C1 - inaktivátory genetika MeSH
- lidé MeSH
- mutační analýza DNA MeSH
- nesmyslný kodon genetika MeSH
- polymorfismus genetický genetika MeSH
- posunová mutace genetika MeSH
- sekvenční delece genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- inhibiční protein komplementu C1 MeSH
- komplement C1 - inaktivátory MeSH
- nesmyslný kodon MeSH
Hereditary angioedema (HAE) is a disorder characterised by recurrent attacks of localized subcutaneous or submucosal edema. It is inherited in an autosomal dominant fashion and caused by a deficiency of C1 inhibitor (C1 inh, or C1NH). Most patients with HAE have an absolute deficiency of C1 inh (type I HAE) while the rest (15% of kindreds) synthetize a dysfunctional C1 inh protein (type II HAE). In this report a novel use of denaturing gradient gel electrophoresis (DGGE) followed by direct sequencing of the C1 inhibitor gene is presented. Five novel mutations, one nonsense (p.S48X) and four small deletions resulting in frameshifts (g.2264-2265delAG, g.2304delC, g.8493-8494delCC and g.16676-16677delTG) have been identified in the C1 inhibitor gene in five families with type I HAE. All of these mutations lead to premature termination of translation and thus can be considered causative of the C1 inh deficiency. Moreover, two previously described mutations in the reactive center of C1 inh, p.R444C and p.R444H, have been detected in four unrelated patients with type II HAE.
Citace poskytuje Crossref.org
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation